Citius Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTOR and other ETFs, options, and stocks.About CTOR
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CTOR Key Statistics
Stock Snapshot
With a market cap of 84.47M, Citius Oncology(CTOR) trades at $0.97. The stock has a price-to-earnings ratio of -3.10.
Citius Oncology(CTOR) stock opened on 2026-05-06 at $0.93. The price climbed to — and dipped to —.
Citius Oncology(CTOR) shares are trading with a volume of 0, against a daily average of 107.29K.
During the past year, Citius Oncology(CTOR) stock moved between $0.49 at its lowest and $6.19 at its peak.
During the past year, Citius Oncology(CTOR) stock moved between $0.49 at its lowest and $6.19 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.